Archive for the ‘Victrelis’ Category

Merck’s Hepatitis C Drug Wins F.D.A. Approval

by By ANDREW POLLACK Posted: Saturday, 5/14/2011
Victrelis, from Merck, is the first of a new generation of drugs that promise to increase the cure rate while shortening the treatment time.

Posted in All, Drugs (Pharmaceuticals), Food and Drug Administration, Hepatitis, Medicine and Health, Merck & Company Inc|MRK|NYSE, Victrelis | Comments Off